Pierce Kristen 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Pierce Kristen
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+200,000→ 200,000 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in twenty-four (24) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.